Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. Fink JL. Dispensing Wrong Medications Leads to Patient's Death. September 2019. https://www.pharmacytimes.com/view/dispensing-wrong-medications-leads-to-patients-death. (Accessed August 1, 2025).
2. World Health Organization. WHO launches global effort to halve medication-related errors in 5 years. March 2017. https://www.who.int/news-room/detail/29-03-2017-who-launches-global-effort-to-halve-medication-related-errors-in-5-years. (Accessed August 1, 2025).
3. Desjardins L. Thousands die from medical errors yearly, notes advocacy group. October 2019. https://www.rcinet.ca/en/2019/10/28/thousands-die-from-medical-errors-yearly-notes-advocacy-group/. (Accessed August 1, 2025).
4. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err is Human: Building a Safer Health System. Washington, DC: National Academies Press (U.S.); 2000.
6. Billstein-Leber M, Carrillo JD, Angela T. Cassano AT, et al. ASHP Guidelines on Preventing Medication Errors in Hospitals. Am J Health-System Pharm. 2018 Oct;75(19):1493-1517.
7. Hutton B, Kanji S, McDonald E, et al. Incidence, causes, and consequences of preventable adverse drug events: protocol for an overview of reviews. Syst Rev. 2016 Dec;5(1):209.
8. Bourgeois FT, Shannon MW, Valim C, Mandl KD. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010 Sep;19(9):901-10.
9. US Food and Drug Administration. Safe Use Initiative. August 2022. https://www.fda.gov/drugs/drug-safety-and-availability/safe-use-initiative. (Accessed August 1, 2025).
10. US Food and Drug Administration. Safe Use Initiative – Current Projects. October 2019. https://www.fda.gov/drugs/safe-use-initiative/safe-use-initiative-current-projects. (Accessed August 1, 2025).
11. ISMP Canada. Canadian Medication Incident Reporting and Prevention System (CMIRPS). https://www.ismp-canada.org/cmirps/. (Accessed August 1, 2025).
12. National Coordinating Council for Medication Error Reporting and Prevention. What is a Medication Error? http://www.nccmerp.org/about-medication-errors. (Accessed August 1, 2025).
13. National Coordinating Council for Medication Error Reporting and Prevention. Recommendations to enhance accuracy of dispensing medications. June 2015.
14. https://www.nccmerp.org/recommendations-enhance-accuracy-dispensing-medications. (Accessed August 1, 2025).
15. ISMP. ISMP survey helps define near miss and close call. September 24, 2009. https://home.ecri.org/pages/ismp. (Accessed August 1, 2025).
16. Agency for Healthcare Research and Quality. Patient Safety Network. Glossary. https://psnet.ahrq.gov/glossary. (Accessed August 1, 2025).
17. Hughes RG, Blegen MA. Medication Administration Safety. In: Hughes RF, Ed. Patient Safety and Quality: An Evidence-Based Handbook for Nurses. Rockville, MD: Agency for Healthcare Research and Quality, 2008.
18. Winterstein AG, Johns TE, Rosenberg EI, et al. Nature and causes of clinically significant medication errors in a tertiary care hospital. Am J Health Syst Pharm. 2004 Sep;61(18):1908-16.
19. Healthcare Providers Service Organization. Pharmacist Professional Liability Exposure Claim Report: 3rd Edition. https://www.hpso.com/getmedia/261a3590-6368-41e6-857c-f2bf9dbdf6ea/CNA_CLS_PHARM_072823_CF_PROD_SEC-(1).pdf. (Accessed August 1, 2025).
20. Abramson EL, Bates DW, Jenter C, et al. Ambulatory prescribing errors among community-based providers in two states. J Am Med Inform Assoc. 2012 Jul-Aug;19(4):644-8.
21. Kennedy AG, Littenberg B. A modified outpatient prescription form to reduce prescription errors. Jt Comm J Qual Saf. 2004 Sep;30(9):480-7.
22. National Coordinating Council for Medication Error Reporting and Prevention. Recommendations to enhance accuracy of prescription/medication order writing. October 2014. https://www.nccmerp.org/recommendations-enhance-accuracy-prescription-writing. (Accessed August 1, 2025).
24. Jani YH, Ghaleb MA, Marks SD, et al. Electronic prescribing reduced prescribing errors in a pediatric renal outpatient clinic. J Pediatr. 2008 Feb;152(2):214-8.
25. Phillips JL, Shea JM, Leung V, MacDonald D. Impact of early electronic prescribing on pharmacists’ clarification calls in four community pharmacies located in St John’s, Newfoundland. JMIR Med Inform. 2015 Jan;3(1):e2.
26. Surescripts. 2022 National Progress Report. https://surescripts.widen.net/s/mvtqvvf5sd/2022-national-progress-report. (Accessed August 1, 2025).
27. Centers for Medicare and Medicaid Services. EPCS: Electronic Prescribing for Controlled Substances Frequently Asked Questions. https://www.cms.gov/files/document/epcs-frequently-asked-questions.pdf-0. (Accessed August 1, 2025).
28. Surescripts. Annual Impact Report 2024. https://surescripts.widen.net/s/hdf8b99xvw/annual-impact-report-2024. (Accessed August 1, 2025).
30. Kowiatek JG, Weber RJ, Skledar S, et al. Assessing and monitoring override medications in automated dispensing devices. Jt Comm J Qual Patient Saf. 2006;32:309-17.
31. American Society of Health-System Pharmacists. ASHP guidelines on the safe use of automated dispensing devices. Am J Health-Syst Pharm.2010;67:483-90.
32. Carrillo-Martin I, Gonzalez-Estrada A, Funni SA, et al. Increasing allergy-related emergency department visits in the United States, 2007 to 2015. J Allergy Clin Immunol Pract. 2020 Oct;8(9):2983-2988.
33. Rogers E, Griffin E, Carnie W, et al. A Just Culture approach to managing medication errors. Hosp Pharm. 2017 Apr;52(4):308-315.
34. ISMP. Just Culture and its critical link to patient safety (part I). May 17, 2012. https://home.ecri.org/pages/ismp. (Accessed August 1, 2025).
35. The Joint Commission. Do Not Use List/Prohibited Abbreviations. https://www.jointcommission.org/en-us/knowledge-library/support-center/standards-interpretation/do-not-use-list-of-abbreviations. (Accessed August 1, 2025).
36. ISMP. List of Error-Prone Abbreviations. April 2024. https://home.ecri.org/pages/ismp. (Accessed August 1, 2025).
37. Li Q, Kawano A, Ho C. Look-alike/sound-alike drug names. February 2016. https://www.ismp-canada.org. (Accessed August 1, 2025).
38. ISMP. List of Confused Drug Names. August 2024. https://home.ecri.org/pages/ismp. (Accessed May 29, 2025).
39. US Food and Drug Administration. FDA Drug Safety Communication: Important change to heparin container labels to clearly state the total drug strength. January 2016. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-important-change-heparin-container-labels-clearly-state-total-drug. (Accessed August 1, 2025).
40. US Food and Drug Administration. Medication Errors Related to CDER-Regulated Drug Products. January 2024. https://www.fda.gov/drugs/drug-safety-and-availability/medication-errors-related-cder-regulated-drug-products#. (Accessed August 1, 2025).
41. Takeda. Kapdiex (dexlansoprazole) Renamed Dexilant in U.S. to Avoid Name Confusion. March 2010. https://www.takeda.com/en-us/newsroom/news-releases/2010/kapidex-dexlansoprazole-renamed-dexilant-in-us-to-avoid-name-confusion/. (Accessed August 1, 2025).
42. US Food and Drug Administration. FDA Drug Safety Communication: FDA approves brand name change for antidepressant drug Brintellix (vortioxetine) to avoid confusion with antiplatelet drug Brilinta (ticagrelor). June 2016. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-approves-brand-name-change-antidepressant-drug-brintellix. (Accessed August 1, 2025).
43. ISMP. Look-Alike Drug Names with Recommended Tall Man (Mixed Case) Letters. January 2023. https://home.ecri.org/pages/ismp. (Accessed August 1, 2025).
44. Cohen MR. Something’s lost in translation. Nursing. 2005 May;35(12). https://journals.lww.com/nursing/citation/2005/05000/something_s_lost_in_translation.8.aspx. (Accessed August 1, 2025).
45. Anthony S. Avoiding Problems: Managing the Risks in Hospital Practice. May 2012. https://www.medicalprotection.org/ireland/resources-training. (Accessed August 1, 2025).
46. National Coordinating Council for Medication Error Reporting and Prevention. Recommendation for Manufacturers, Regulators, and Standards Setters to Promote the Safe Use of Modifiers in Prescription Drug Proprietary (Brand) Names. March 2023. http://www.nccmerp.org/recommendation-manufacturers-regulators-and-standards-setters-promote-safe-use-modifiers. (Accessed August 1, 2025).
47. US Food and Drug Administration. Human Factors: Postmarket Information – Device Surveillance and Reporting Processes. September 2018. https://www.fda.gov/medical-devices/human-factors-and-medical-devices/postmarket-information-device-surveillance-and-reporting-processes. (Accessed August 1, 2025).
48. Lehne RA. Drug Regulation, Development, Names, and Information. In: Pharmacology for Nursing Care. 8th Ed. St. Louis, MO: Elsevier Saunders, 2013:22.
49. US Food and Drug Administration. Vantin. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process. (Accessed August 1, 2025).
50. Drugs.com. Zertalin. https://www.drugs.com/international/zertalin.html. (Accessed August 1, 2025).
51. National Coordinating Council for Medication Error Reporting and Prevention. Reducing Medication Errors Associated with At-risk Behaviors by Healthcare Professionals. July 2025. https://www.nccmerp.org/reducing-medication-errors-associated-risk-behaviors-healthcare-professionals. (Accessed August 1, 2025).
52. van der Sijs H, Mulder A, van Gelder T, et al. Drug safety alert generation and overriding in a large Dutch university medical centre. Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):941-7.
53. Affrime MB, Lowenthal DT, Tobert JA, et al. Dynamics and kinetics of ophthalmic timolol. Clin Pharmacol Ther. 1980 Apr;27(4):471-7.
54. Alvan G, Calissendorff B, Seideman P, Widmark K, Widmark G. Absorption of ocular timolol. Clin Pharmacokinet. 1980 Jan-Feb;5(1):95-100.
55. Foong AL, Grindrod KA, Patel T, Kellar J. Demystifying serotonin syndrome (or serotonin toxicity). Can Fam Physician. 2018 Oct;64(10):720-727.
56. Foong AL, Patel T, Kellar J, Grindrod KA. The scoop on serotonin syndrome. Can Pharm J (Ott). 2018 May 30;151(4):233-239.
57. Scotton WJ, Hill LJ, Williams AC, Barnes NM. Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. Int J Tryptophan Res. 2019 Sep 9;12:1178646919873925.
58. Baldo BA, Rose MA. The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review. Br J Anaesth. 2020 Jan;124(1):44-62.
59. Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, Simmons KB, Pagano HP, Jamieson DJ, Whiteman MK. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016 Jul 29;65(3):1-103.
60. National Coordinating Council for Medication Error Reporting and Prevention. Recommendations to Reduce Medication Errors Associated With Verbal Medication Orders and Prescriptions. May 2015. https://www.nccmerp.org/recommendations-reduce-medication-errors-associated-verbal-medication-orders-and-prescriptions. (Accessed August 1, 2025).
61. ISMP. Despite Technology, Verbal Orders Persist, Read Back is Not Widespread, and Errors Continue. June 2017. https://www.ismp.org/sites/default/files/attachments/2018-03/NurseAdviseERR201706.pdf. (Accessed August 1, 2025).
62. Svarstad BL, Mount JK, Tabak ER. Expert and consumer evaluation of patient medication leaflets provided in U.S. pharmacies. J Am Pharm Assoc (2003). 2005 Jul-Aug;45(4):443-51.
63. Center for Health Care Strategies. Health Literacy Fact Sheets. March 2024. https://www.chcs.org/resource/health-literacy-fact-sheets/. (Accessed August 1, 2025).
64. Lesar TS, Lomaestro BM, Pohl H. Medication-prescribing errors in a teaching hospital. A 9-year experience. Arch Intern Med. 1997 Jul 28;157(14):1569-76.
65. Suh DC, Woodall BS, Shin SK, Hermes-De Santis ER. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother. 2000 Dec;34(12):1373-9.
66. ISMP. High-Alert Medications in Acute Care Settings. January 2024. https://home.ecri.org/pages/ismp. (Accessed August 1, 2025).
67. ISMP. High-Alert Medications in Community/Ambulatory Settings. September 2021. https://home.ecri.org/pages/ismp. (Accessed August 1, 2025).
68. Weingart SN, Toro J, Spencer J, et al. Medication errors involving oral chemotherapy. Cancer. 2010 May;116(10):2455-64.
69. Fortescue EB, Kaushal R, Landrigan CP, et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics. 2003 Apr;111(4 Pt 1):722-9.
70. Torjesen I. How do we ensure pharmacist have the skills they need for their expanding role? August 2015. https://pharmaceutical-journal.com/article/news/how-do-we-ensure-pharmacists-have-the-skills-they-need-for-their-expanding-role. (Accessed August 1, 2025).
71. Mohsin-Shaikh S, Garfield S, Franklin BD. Patient involvement in medication safety in hospital: an exploratory study. Int J Clin Pharm. 2014 Jun;36(3):657-66.
72. Alberta Health Services. Know your medicines. July 2024. https://myhealth.alberta.ca/Alberta/Pages/know-your-medications.aspx. (Accessed August 1, 2025).
73. ISMP Canada. Informed patients can reduce risk of medication errors. October 2000. https://ismpcanada.ca/. (Accessed August 1, 2025).
74. ASHP policy positions: automation and information technology. In: Hawkins B, ed. Best Practices: Positions and Guidance Documents of ASHP. 2015–2016 ed. Bethesda, MD: American Society of Health-System Pharmacists; 2015:4.
75. Odukoya OK, Stone JA, Chui MA. E-prescribing errors in community pharmacies: exploring consequences and contributing factors. Int J Med Inform. 2014 Jun;83(6):427–37.
76. Leapfrog Hospital Survey. Factsheet: Computerized Physician Order Entry. April 2024. https://ratings.leapfroggroup.org/sites/default/files/2024-03/2024%20CPOE%20Fact%20Sheet.pdf. (Accessed August 1, 2025).
77. Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA. 2005 Mar;293(10):1197-203.
78. ISMP Canada, Canada Patient Safety Institute. Medication bar code system implementation planning: A resource guide. September 2013. https://www.ismp-canada.org/barcoding/download/ResourceGuide/BarCodingResourceGuideFINAL.pdf. (Accessed August 1, 2025).
79. Joint Commission. Quick Safety Issue 26: Transitions of Care: Managing Medications (Updated April 2022). April 2022. https://www.jointcommission.org/en-us/knowledge-library/newsletters/quick-safety/issue-26. (Accessed August 1, 2025).
80. American Society of Health-System Pharmacists. ASHP statement on the pharmacist’s role in medication reconciliation. Am J Health-Syst Pharm.2013;70:453–6.
81. World Health Organization. Medication Safety in Transitions of Care. 2019. https://apps.who.int/iris/bitstream/handle/10665/325453/WHO-UHC-SDS-2019.9-eng.pdf;sequence=1. (Accessed September 15, 2025).
83. Tam VC, Knowles SR, Cornish PL, et al. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. CMAJ. 2005 Aug;173(5):510-5.
84. Lisby M, Nielsen LP, Mainz J. Errors in the medication process: frequency, type, and potential clinical consequences. Int J Qual Health Care. 2005 Feb;17(1):15-22.
85. Polnariev A. What to do when you make a medication error. September 2016. https://www.pharmacytimes.com/contributor/alan-polnariev-pharmd-ms-cgp/2016/09/what-to-do-when-you-make-a-medication-error. (Accessed August 1, 2025).
86. ISMP. Improving medication safety in community pharmacy: assessing risk and opportunities for change. February 5, 2009. https://www.ismp.org/sites/default/files/attachments/2018-02/ISMP_AROC_whole_document.pdf.(Accessed August 1, 2025).
87. Grissinger M. Too many abandon the “second victims” of medical errors. P T. 2014 Sep;39(9):591-2.
89. Agency for Healthcare Research and Quality. Root cause analysis. June 2024. https://psnet.ahrq.gov/primer/root-cause-analysis?q=/primers/primer/10. (Accessed August 5, 2025).
90. Centers for Medicare and Medicaid Services. Guidance for Performing Root Cause Analysis with Performance Improvement Projects. https://www.cms.gov/medicare/provider-enrollment-and-certification/qapi/downloads/guidanceforrca.pdf. (Accessed August 1, 2025).
91. ISMP. ISMP Community Pharmacy Template for Root Cause Analysis and Action Plan. https://www.ismp.org/sites/default/files/attachments/2018-01/ISMP52-RCA-Template%20Root%20CA%20%26%20Action%20Plan-020414.pdf. (Accessed August 1, 2025).
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.